291 related articles for article (PubMed ID: 37474262)
1. Deliberation on debilitating condition of cancer cachexia: Skeletal muscle wasting.
Dave S; Patel BM
Fundam Clin Pharmacol; 2023 Dec; 37(6):1079-1091. PubMed ID: 37474262
[TBL] [Abstract][Full Text] [Related]
2. Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.
Siddiqui JA; Pothuraju R; Jain M; Batra SK; Nasser MW
Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188359. PubMed ID: 32222610
[TBL] [Abstract][Full Text] [Related]
3. Exercise as an anti-inflammatory therapy for cancer cachexia: a focus on interleukin-6 regulation.
Daou HN
Am J Physiol Regul Integr Comp Physiol; 2020 Feb; 318(2):R296-R310. PubMed ID: 31823669
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia.
Yoshida T; Tabony AM; Galvez S; Mitch WE; Higashi Y; Sukhanov S; Delafontaine P
Int J Biochem Cell Biol; 2013 Oct; 45(10):2322-32. PubMed ID: 23769949
[TBL] [Abstract][Full Text] [Related]
5. Cancer-Mediated Muscle Cachexia: Etiology and Clinical Management.
Siff T; Parajuli P; Razzaque MS; Atfi A
Trends Endocrinol Metab; 2021 Jun; 32(6):382-402. PubMed ID: 33888422
[TBL] [Abstract][Full Text] [Related]
6. TNF-α and cancer cachexia: Molecular insights and clinical implications.
Patel HJ; Patel BM
Life Sci; 2017 Feb; 170():56-63. PubMed ID: 27919820
[TBL] [Abstract][Full Text] [Related]
7. The role of TGF-β signaling in muscle atrophy, sarcopenia and cancer cachexia.
Lan XQ; Deng CJ; Wang QQ; Zhao LM; Jiao BW; Xiang Y
Gen Comp Endocrinol; 2024 Jul; 353():114513. PubMed ID: 38604437
[TBL] [Abstract][Full Text] [Related]
8. Aerobic exercise training as therapy for cardiac and cancer cachexia.
Alves CR; da Cunha TF; da Paixão NA; Brum PC
Life Sci; 2015 Mar; 125():9-14. PubMed ID: 25500304
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of peripheral muscle wasting in cardiac cachexia.
Filippatos GS; Anker SD; Kremastinos DT
Curr Opin Clin Nutr Metab Care; 2005 May; 8(3):249-54. PubMed ID: 15809526
[TBL] [Abstract][Full Text] [Related]
10. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
[TBL] [Abstract][Full Text] [Related]
11. Protein breakdown in cancer cachexia.
Sandri M
Semin Cell Dev Biol; 2016 Jun; 54():11-9. PubMed ID: 26564688
[TBL] [Abstract][Full Text] [Related]
12. 2-Deoxy-D-glucose Alleviates Cancer Cachexia-Induced Muscle Wasting by Enhancing Ketone Metabolism and Inhibiting the Cori Cycle.
Wei L; Wang R; Wazir J; Lin K; Song S; Li L; Pu W; Zhao C; Wang Y; Su Z; Wang H
Cells; 2022 Sep; 11(19):. PubMed ID: 36230949
[TBL] [Abstract][Full Text] [Related]
13. Cucurbitacin IIb attenuates cancer cachexia induced skeletal muscle atrophy by regulating the IL-6/STAT3/FoxO signaling pathway.
Wang Y; Sun X; Yang Q; Guo C
Phytother Res; 2023 Aug; 37(8):3380-3393. PubMed ID: 37073890
[TBL] [Abstract][Full Text] [Related]
14. STAT3 in the systemic inflammation of cancer cachexia.
Zimmers TA; Fishel ML; Bonetto A
Semin Cell Dev Biol; 2016 Jun; 54():28-41. PubMed ID: 26860754
[TBL] [Abstract][Full Text] [Related]
15. Muscle wasting in cancer: the role of mitochondria.
Argilés JM; López-Soriano FJ; Busquets S
Curr Opin Clin Nutr Metab Care; 2015 May; 18(3):221-5. PubMed ID: 25769061
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of metabolic dysfunction in cancer-associated cachexia.
Petruzzelli M; Wagner EF
Genes Dev; 2016 Mar; 30(5):489-501. PubMed ID: 26944676
[TBL] [Abstract][Full Text] [Related]
17. Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies.
Dodson S; Baracos VE; Jatoi A; Evans WJ; Cella D; Dalton JT; Steiner MS
Annu Rev Med; 2011; 62():265-79. PubMed ID: 20731602
[TBL] [Abstract][Full Text] [Related]
18. [Systemic and local mechanisms leading to cachexia in cancer].
Grabiec K; Burchert M; Milewska M; Błaszczyk M; Grzelkowska-Kowalczyk K
Postepy Hig Med Dosw (Online); 2013 Dec; 67():1397-409. PubMed ID: 24493689
[TBL] [Abstract][Full Text] [Related]
19. Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment.
Miyamoto Y; Hanna DL; Zhang W; Baba H; Lenz HJ
Clin Cancer Res; 2016 Aug; 22(16):3999-4004. PubMed ID: 27340276
[TBL] [Abstract][Full Text] [Related]
20. IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway.
Liu D; Qiao X; Ge Z; Shang Y; Li Y; Wang W; Chen M; Si S; Chen SZ
Skelet Muscle; 2019 Mar; 9(1):8. PubMed ID: 30922397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
